TRIlogy-3
A Phase 2, Open-label Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Who Have Received at Least 3 Prior Lines of Therapy Including a PI, an IMiD, and an Anti-CD38 Antibody
Near Add Your Location
Sorting 42 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Accepting patients
- Accepting patients
Cancer Specialists of North Florida
Fleming Island, FL
- Accepting patients
Texas Oncology
Waco, TX
- Accepting patients
Oncology Consultants PA
Houston, TX
- Accepting patients
- Accepting patients
Cancer and Blood Specialty Clinic
Los Alamitos, CA
- Accepting patients
City of Hope
Zion, IL
- Accepting patients
Cancer Care Center of O'Fallon
O'Fallon, IL
- Accepting patients
Colorado Blood Cancer Institute
Sarah Cannon at Presbyterian/St. Luke's Medical Center (HealthONE)
Denver, CO
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.